FDA recall D-0005-2025

Gilead Sciences, Inc. · Class I · drug

Product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for recall

Presence of Particulate Matter: Presence of glass particle.

Distribution

Nationwide in the U.S.A.

Key facts

Status
Terminated
Initiation date
2024-09-19
Report date
2024-10-09
Termination date
2025-07-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Foster City, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0005-2025